ScholarIQanswers from OpenAlex

Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways

PaperCitations, authors & open-access status

Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways have?

ScholarIQcitation count

Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways has 92 citations in the OpenAlex counts ScholarIQ stores.

When was Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways published?

ScholarIQyear

Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways has 2015 year in the ScholarIQ index.

What is the open-access status of Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways?

ScholarIQoa status

Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways has bronze oa status in the ScholarIQ index.

What is the DOI of Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways?

ScholarIQdoi

The DOI for Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways is on the source record.

What is the PMID of Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways?

ScholarIQpmid

The PMID for Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways is on the source record.

What is the OpenAlex record for Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways?

ScholarIQopenalex

The OpenAlex for Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial